+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Eubiotics Market Size, Share & Industry Trends Analysis Report By Product, By Application, By Form, By End-use, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 97 Pages
  • May 2022
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5615873
The Latin America, Middle East and Africa Eubiotics Market is expected to witness market growth of 10.4% CAGR during the forecast period (2022-2028).

In comparison to the initial generation of these medications, today's eubiotics provide more consistent outcomes. Some eubiotic substances have a consistent response to outdoor stimuli, especially in young birds. They help to create the gut microbiota by boosting lactobacilli development via the synthesis of lactic acid and bacteriocins. This helps to prevent the growth of harmful germs like Salmonella. Despite these advancements, probiotic effectiveness is extremely reliant on the experimental paradigm utilized, and only a few of them show clearly repeatable favorable results.

When a calf is born, there is a window of opportunity to instill excellent health. It is crucial to offer support for the growing immune response during the essential first few weeks of life by administering eubiotics to calves early on to assist preserve normal GI health. Around 70% of the immune system is located in or around the digestive system. Maintaining good intestinal health in a calf's early years is critical to rearing a fast-growing animal with a strong, functioning immune system.

The South African government and the poultry sector agreed to a Chicken Sector Master Plan in November 2019, which aims to boost poultry production and protect local domestic farmers from unfair trade tactics and imports. Increased import duties are one of the strategies that is expected to be employed to achieve the latter goal. The International Trade Administration Commission approved the South African Poultry Association's (SAPA) request for import duty increases on bone-in and boneless chicken imports in March 2020.

South Africa manufactures 19.6 million birds per week, making the poultry industry the largest agricultural product sector in the country, surpassing all other animal sectors and all field crop and horticulture industries. The industry faces high manufacturing costs, which influence annual productivity. High feed costs dominate their production expenses, reducing the poultry industry's competitiveness.

The Brazil market dominated the LAMEA Eubiotics Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $164.2 million by 2028. The Argentina market is poised to grow at a CAGR of 10.9% during (2022 - 2028). Additionally, The Egypt market is expected to display a CAGR of 9.7% during (2022 - 2028).

Based on Product, the market is segmented into Probiotics, Organic Acids, Phytogenic, Prebiotics, and Enzymes. Based on Application, the market is segmented into Gut Health, Immunity, Yield, and Others. Based on Form, the market is segmented into Solid and Liquid. Based on End-use, the market is segmented into Poultry Feed, Swine Feed, Cattle Feed, Aquatic Feed, and Others. Based on countries, the market is segmented into Brazil, Argentina, Egypt, Tanzania, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., Novozymes A/S, BASF SE, DuPont de Nemours, Inc., Chr. Hansen holding A/S, Lallemand, Inc., Lesaffre Group, Kemin Industries, Inc., Cargill Corporation, and Calpis Co., Ltd.

By Product

  • Probiotics
  • Organic Acids
  • Phytogenic
  • Prebiotics
  • Enzymes

By Application

  • Gut Health
  • Immunity
  • Yield
  • Others

By Form

  • Solid
  • Liquid

By End-use

  • Poultry Feed
  • Swine Feed
  • Cattle Feed
  • Aquatic Feed
  • Others

By Country

  • Brazil
  • Argentina
  • Egypt
  • Tanzania
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players


List of Companies Profiled in the Report:

  • Koninklijke DSM N.V.
  • Novozymes A/S
  • BASF SE
  • DuPont de Nemours, Inc.
  • Chr. Hansen holding A/S
  • Lallemand, Inc.
  • Lesaffre Group
  • Kemin Industries, Inc.
  • Cargill Corporation
  • Calpis Co., Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Eubiotics Market, by Product
1.4.2 LAMEA Eubiotics Market, by Application
1.4.3 LAMEA Eubiotics Market, by Form
1.4.4 LAMEA Eubiotics Market, by End-use
1.4.5 LAMEA Eubiotics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Eubiotics Market
Chapter 4. LAMEA Eubiotics Market by Product
4.1 LAMEA Probiotics Market by Country
4.2 LAMEA Organic Acids Market by Country
4.3 LAMEA Phytogenic Market by Country
4.4 LAMEA Prebiotics Market by Country
4.5 LAMEA Enzymes Market by Country
Chapter 5. LAMEA Eubiotics Market by Application
5.1 LAMEA Gut Health Market by Country
5.2 LAMEA Immunity Market by Country
5.3 LAMEA Yield Market by Country
5.4 LAMEA Others Market by Country
Chapter 6. LAMEA Eubiotics Market by Form
6.1 LAMEA Solid Market by Country
6.2 LAMEA Liquid Market by Country
Chapter 7. LAMEA Eubiotics Market by End-use
7.1 LAMEA Poultry Feed Market by Country
7.2 LAMEA Swine Feed Market by Country
7.3 LAMEA Cattle Feed Market by Country
7.4 LAMEA Aquatic Feed Market by Country
7.5 LAMEA Others Market by Country
Chapter 8. LAMEA Eubiotics Market by Country
8.1 Brazil Eubiotics Market
8.1.1 Brazil Eubiotics Market by Product
8.1.2 Brazil Eubiotics Market by Application
8.1.3 Brazil Eubiotics Market by Form
8.1.4 Brazil Eubiotics Market by End-use
8.2 Argentina Eubiotics Market
8.2.1 Argentina Eubiotics Market by Product
8.2.2 Argentina Eubiotics Market by Application
8.2.3 Argentina Eubiotics Market by Form
8.2.4 Argentina Eubiotics Market by End-use
8.3 Egypt Eubiotics Market
8.3.1 Egypt Eubiotics Market by Product
8.3.2 Egypt Eubiotics Market by Application
8.3.3 Egypt Eubiotics Market by Form
8.3.4 Egypt Eubiotics Market by End-use
8.4 Tanzania Eubiotics Market
8.4.1 Tanzania Eubiotics Market by Product
8.4.2 Tanzania Eubiotics Market by Application
8.4.3 Tanzania Eubiotics Market by Form
8.4.4 Tanzania Eubiotics Market by End-use
8.5 South Africa Eubiotics Market
8.5.1 South Africa Eubiotics Market by Product
8.5.2 South Africa Eubiotics Market by Application
8.5.3 South Africa Eubiotics Market by Form
8.5.4 South Africa Eubiotics Market by End-use
8.6 Nigeria Eubiotics Market
8.6.1 Nigeria Eubiotics Market by Product
8.6.2 Nigeria Eubiotics Market by Application
8.6.3 Nigeria Eubiotics Market by Form
8.6.4 Nigeria Eubiotics Market by End-use
8.7 Rest of LAMEA Eubiotics Market
8.7.1 Rest of LAMEA Eubiotics Market by Product
8.7.2 Rest of LAMEA Eubiotics Market by Application
8.7.3 Rest of LAMEA Eubiotics Market by Form
8.7.4 Rest of LAMEA Eubiotics Market by End-use
Chapter 9. Company Profiles
9.1 Koninklijke DSM N.V.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisitions and Mergers:
9.1.5.3 Product Launches and Product Expansions:
9.2 Novozymes A/S
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 BASF SE
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.4 DuPont de Nemours, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Chr. Hansen Holding A/S
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Lallemand, Inc.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Partnerships, Collaborations, and Agreements:
9.7 Lesaffre Group
9.7.1 Company Overview
9.7.2 Recent strategies and developments:
9.7.2.1 Partnerships, Collaborations, and Agreements:
9.8 Kemin Industries, Inc.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Product Launches and Product Expansions:
9.9 Cargill Corporation
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Product Launches and Product Expansions:
9.10. Calpis Co., Ltd. (Asahi Group Holdings, Ltd.)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental Analysis
9.10.4 Recent strategies and developments:
9.10.4.1 Approvals and Trials:

Companies Mentioned

  • Koninklijke DSM N.V.
  • Novozymes A/S
  • BASF SE
  • DuPont de Nemours, Inc.
  • Chr. Hansen holding A/S
  • Lallemand, Inc.
  • Lesaffre Group
  • Kemin Industries, Inc.
  • Cargill Corporation
  • Calpis Co., Ltd.

Methodology

Loading
LOADING...